Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma

Oncology Reports

Volumn 18, Issue 6, 2007, Pages 1427-1434

  Brusa, Gianluca ^a   Zuffa, Elisa ^a   Hattinger, Claudia Maria ^b   Serra, Massimo ^b   Remondini, Daniel ^a,b   Castellani, Gastone ^a   Righi, Simona ^a   Campidelli, Cristina ^a   Pileri, Stefano ^a   Zinzani, Pier Luigi ^a   Gabriele, Annalisa ^a   Mancini, Manuela ^a   Corrado, Patrizia ^a   Barbieri, Enza ^a   Santucci, Maria Alessandra ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Array based comparative genomic hybridization; Genomic instability; Hodgkin lymphoma; Secondary acute leukemias

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME MAP; DNA REPAIR; DNA REPLICATION; GENE DELETION; GENETICS; GENOMIC INSTABILITY; HODGKIN DISEASE; HUMAN; ISOLATION AND PURIFICATION; SECOND CANCER;

CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA REPAIR; DNA REPLICATION; DNA, NEOPLASM; GENE DELETION; GENOMIC INSTABILITY; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASMS, SECOND PRIMARY; NUCLEAR PROTEINS; ONCOGENE PROTEINS;

EID: 38449087906     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.6.1427     Document Type: Article

References (21)

1. Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA and Greene MH: Cancer survivorship-genetic susceptibility and second primary cancers: research strategies and recommendations: Review. J Natl Cancer Inst 98: 15-25, 2006. (Pubitemid 43057089)
2. Brauninger A, Schmitz R, Bechtel D, Renne C, Hansmann ML and Kuppers R: Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer 118: 1853-1861, 2006.
3. Re D, Zander T, Dieh V and Wolf J: Genetic instability in Hodgkin's lymphoma. Ann Oncol 13 (Suppl 1): 19-22, 2002. (Pubitemid 34567396)
4. Barrios L, Caballin MR, Miro R, Fuster C, Berrozpe G, Subias A, Batlle X and Egozcue J: Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients. A possible evidence for chromosome instability. Hum Genet 78: 320-324, 1988.
5. Erdkamp FL, Schouten HC, Breed WP, Janssen WC, Hoffmann JJ, Schutte B and Blijham GH: DNA aneuploidy in Hodgkin's disease: a multiparameter flow cytometric analysis. Leuk Lymphoma 12: 297-306, 1994. (Pubitemid 24077180)
6. Schlegelberger B, Weber-Matthiesen K, Sterry W, Bartels H, Sonnen R, Maschmeyer G, Feller AC and Grote W: Combined immunophenotyping and karyotyping in peripheral T cell lymphomas demonstrating different clonal and nonclonal chromosome aberrations in T helper cells. Leuk Lymphoma 15: 113-125, 1994. (Pubitemid 24303387)
7. Jansen MP, Hopman AH, Haesevoets AM, Gennotte IA, Bot FJ, Arends JW, Ramaekers FC and Schouten HC: Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells. J Pathol 185: 145-152, 1998. (Pubitemid 28270926)
8. Re D, Starostik P, Massoudi N, Staratschek-Jox A, Dries V, Thomas RK, Diehl V and Wolf J: Allelic losses on chromosome 6q25 in Hodgkin and Reed Sternberg cells. Cancer Res 63: 2606-2609, 2003. (Pubitemid 36605202)
9. Wang SS, Davis S, Cerhan JR, Hartge P, Severson RK, Cozen W, Lan Q, Welch R, Chanock SJ and Rothman N: Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 27: 1828-1834, 2006. (Pubitemid 44288664)
10. Shen M, Zheng T, Lan Q, Zhang Y, Zahm SH, Wang SS, Holford TR, Leaderer B, Yeager M, Welch R, Kang D, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S and Rothman N: Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet 119: 659-668, 2006. (Pubitemid 43805843)
11. Re D, Benenson L, Wickenhauser C, Starostik P, Staratschek-Jox A, Muller-Hermelink HK, Diehl V and Wolf J: Proficient mismatch repair protein expression in Hodgkin and Reed Sternberg cells. Int J Cancer 97: 205-210, 2002. (Pubitemid 34019956)
12. Pedersen-Bjergaard J: Insights into leukemogenesis from therapy-related leukemia. N Engl J Med 352: 1591-1594, 2005.
13. Kelly KM and Perentesis JP: Polymorphisms of drug metabolizing enzymes and markers of genotoxicity to identify patients with Hodgkin's lymphoma at risk of treatment-related complications. Ann Oncol 13 (Suppl 1): 34-39, 2002. (Pubitemid 34567399)
14. Jawad M, Seedhouse CH, Russell N and Plumb M: Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukaemia. Blood 108: 3916-3918, 2006. (Pubitemid 44864577)
15. Hattinger CM, Tarkkanen M, Benini S, Pasello M, Stoico G, Bacchini P, Knuutila S, Scotlandi K, Picci P and Serra M: Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. Eur J Cell Biol 83: 483-491, 2004. (Pubitemid 39433528)
16. Liu MT, Chang YT, Chen SC, Chuang YC, Chen YR, Lin CS and Chen JY: Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity. Oncogene 24: 2635-2646, 2005.
17. Sanchez-Aguilera A, Montalban C, de la Cueva P, Sanchez-Verde L, Morente MM, Garcia-Cosio M, Garcia-Larana J, Bellas C, Provencio M, Romagosa V, de Sevilla AF, Menarquez J, Sabin P, Mestre MJ, Mendez M, Fresno MF, Nicolas C, Piris MA, Garcia JF and Spanish Hodgkin Lymphoma Study Group: Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 108: 662-668, 2006.
18. + T lymphocytes in an HLA class II-restricted manner. Blood 106: 1415-1418, 2005.
19. Sasanuma H, Tatsuno A, Hidano S, Ohshima K, Matsuzaki Y, Hayashi K, Lowell CA, Kitamura D and Goitsuka R: Dual function for the adaptor MIST in IFN-gamma production by NK and CD4+NKT cells regulated by the Src kinase Fgr. Blood 107: 3647-3655, 2006.
20. Gurevich P, Aplan DA and Humphries RK: NUP98-Topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation. Blood 104: 1127-1136, 2004.
21. Karajannis MA, Vincent L, Direnzo R, Shmelkov SV, Zhang F, Feldman EJ, Zhu Z, Sun H, Kussie P and Rafii S: Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells. Leukemia 20: 979-986, 2006. (Pubitemid 43797288) University of Bologna